Cargando…
Clinical features and mechanistic insights into drug repurposing for combating COVID-19
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged from Wuhan in China before it spread to the entire globe. It causes coronavirus disease of 2019 (COVID-19) where mostly individuals present mild symptoms, some remain asymptomatic and some show severe lung inflammation and pneumoni...
Autores principales: | Asrani, Purva, Tiwari, Keshav, Eapen, Mathew Suji, McAlinden, Kielan Darcy, Haug, Greg, Johansen, Matt D., Hansbro, Philip M., Flanagan, Katie L., Hassan, Md. Imtaiyaz, Sohal, Sukhwinder Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570392/ https://www.ncbi.nlm.nih.gov/pubmed/34748991 http://dx.doi.org/10.1016/j.biocel.2021.106114 |
Ejemplares similares
-
COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
por: McAlinden, Kielan Darcy, et al.
Publicado: (2020) -
microRNAs Are Key Regulators in Chronic Lung Disease: Exploring the Vital Link between Disease Progression and Lung Cancer
por: Eapen, Mathew Suji, et al.
Publicado: (2019) -
Implications of the second wave of COVID-19 in India
por: Asrani, Purva, et al.
Publicado: (2021) -
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
por: Brake, Samuel James, et al.
Publicado: (2020) -
Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD)
por: Eapen, Mathew Suji, et al.
Publicado: (2017)